Knoll Capital Management, LLC — 13F Holdings & Portfolio
CIK 1325083 · latest 13F-HR filed 2026-08-14
Knoll Capital Management, LLC manages $179.3M in 13F-reported U.S. long-equity assets across 37 reported positions as of its 2026-06-30 13F-HR filing. Its largest disclosed positions are MGTX (9.42%), PHYS (6.51%), ALDX (6.50%). Quarter over quarter (versus its 2026-03-31 filing) the fund opened 1 new position, exited 1, added to 11, and trimmed 21.
AUM is the long-equity portion reported on Form 13F-HR. Excludes short positions, cash, foreign holdings, and non-13F assets. For informational purposes only — not investment advice.
SUITE 800
MIAMI, FL 33131
$179.3M
Long-equity book
37
Distinct positions
2026-06-30
Filed 2026-08-14
+1 / −1 / ↑11 / ↓21
vs 2026-03-31
| Name | Title / Status | Ownership | Type |
|---|
Top Adds (vs prior quarter)
- OR Royalties$7.1M +83088.2%
- Ocular Therapeutix Inc.$6.2M +122.1%
- MeiraGTX Holdings$6.1M +56.0%
- Booz Allen Hamilton HLDG COR$4.7M +461.3%
- Entera Bio Ltd$3.9M +60.9%
Top Trims
- Biohaven Pharmactl Hldg Co-$19.7M -100.0%
- Royal Gold Inc.-$2.9M -21.6%
- Agnico Eagle Mines Ltd-$2.5M -23.6%
- Kinross Gold Corp-$2.2M -22.6%
- Sprott physical gold Trust-$2.0M -14.9%
Rows tagged Call or Put are options positions, not stock. Per SEC Form 13F-HR, Value shows the notional value of the underlying (shares covered × underlying price), not the option premium. Shares is the number of underlying shares covered (divide by 100 for contract count).
| # | Issuer | Symbol | CUSIP | Value | Weight | Shares | Type |
|---|---|---|---|---|---|---|---|
| 1 | MeiraGTX Holdings | MGTX | G59665102 | $16.9M | 9.42% | 1,250,000 | SH |
| 2 | Sprott physical gold Trust | PHYS | 85207H104 | $11.7M | 6.51% | 387,055 | SH |
| 3 | Aldeyra Therapeutics Inc | ALDX | 01438T106 | $11.7M | 6.50% | 5,475,516 | SH |
| 4 | Ocular Therapeutix Inc. | OCUL | 67576A100 | $11.3M | 6.30% | 1,150,400 | SH |
| 5 | Royal Gold Inc. | RGLD | 780287108 | $10.5M | 5.87% | 52,750 | SH |
| 6 | Entera Bio Ltd | ENTX | M40527109 | $10.4M | 5.81% | 5,881,879 | SH |
| 7 | Nuvation Bio Inc | NUVB | 67080N101 | $9.1M | 5.06% | 1,598,591 | SH |
| 8 | Agnico Eagle Mines Ltd | AEM | 008474108 | $8.2M | 4.56% | 52,750 | SH |
| 9 | SEABRIDGE GOLD INC | SA | 811916105 | $8.2M | 4.55% | 317,003 | SH |
| 10 | Kinross Gold Corp | KGC | 496902404 | $7.6M | 4.22% | 320,000 | SH |
| 11 | OR Royalties | OR | 68390D106 | $7.1M | 3.97% | 225,000 | SH |
| 12 | SSR Mining In | SSRM | 784730103 | $6.9M | 3.86% | 245,000 | SH |
| 13 | Franco Nev Corp | FNV | 351858105 | $6.7M | 3.72% | 32,000 | SH |
| 14 | Booz Allen Hamilton HLDG COR | BAH | 099502106 | $5.7M | 3.18% | 13,000 | SH |
| 15 | Centerra Gold Inc | CGAU | 152006102 | $5.7M | 3.18% | 359,000 | SH |
| 16 | Elicio Therapeutics Inc | ELTX | 28657F103 | $4.7M | 2.64% | 1,211,957 | SH |
| 17 | Abivax SA Spons | ABVX | 00370M103 | $4.7M | 2.60% | 35,000 | SH |
| 18 | Pan American Silver | PAAS | 697900108 | $4.5M | 2.50% | 100,035 | SH |
| 19 | Sprott Physical silver Trust | PSLV | 85207K107 | $4.2M | 2.34% | 222,160 | SH |
| 20 | Triple Flag Precious Metals | TFPM | 89679M104 | $3.4M | 1.92% | 115,000 | SH |
| 21 | Abeona Therapeutics | ABEO | 00289Y206 | $3.0M | 1.67% | 485,515 | SH |
| 22 | Gold RTY Corp | GROY | 38071H106 | $2.8M | 1.54% | 1,000,000 | SH |
| 23 | New Pac Metals Corp | NEWP | 64782A107 | $1.9M | 1.09% | 485,000 | SH |
| 24 | iSHares US Aerospace & Defense | ITA | 464288760 | $1.9M | 1.03% | 7,650 | SH |
| 25 | Philip Morris Intl. Inc | PM | 718172109 | $1.8M | 1.01% | 10,000 | SH |
| 26 | Coeur Mining Inc | CDE | 192108504 | $1.6M | 0.87% | 96,132 | SH |
| 27 | Alamos Gold Inc | AGI | 011532108 | $1.5M | 0.85% | 50,000 | SH |
| 28 | Wheaton Precious Metals Corp | WPM | 962879102 | $1.4M | 0.78% | 12,500 | SH |
| 29 | Northrop Grumman Corp | NOC | 666807102 | $1.1M | 0.61% | 2,165 | SH |
| 30 | Elemental RTY Corp | ELE | 28620K106 | $873.0K | 0.49% | 50,000 | SH |
| 31 | Versamet Royalties Corp | VMET | 92528V200 | $820.7K | 0.46% | 66,621 | SH |
| 32 | Dakota Gold Corp | DC | 46655E100 | $523.6K | 0.29% | 122,921 | SH |
| 33 | Amrize LTD | AMRZ | H2927K103 | $489.0K | 0.27% | 9,175 | SH |
| 34 | Altimmune Inc | ALT | 02155H200 | $486.4K | 0.27% | 160,000 | SH |
| 35 | Pharming Group NV | PHAR | 71716E105 | $56.8K | 0.03% | 4,091 | SH |
| 36 | Orgenesis, Inc. | ORGS | 68619K105 | $20.8K | 0.01% | 50,623 | SH |
| 37 | Biohaven Pharmactl Hldg Co | — | G11196105 | $15 | 0.00% | 2,328,602 | SH |
| Period | Filed | AUM | Holdings | Accession |
|---|---|---|---|---|
| 2026-06-30 | 2026-08-14 | $179.3M | 37 | 0001104659-26-097070 |
| 2026-03-31 | 2026-05-15 | $180.2M | 37 | 0001104659-26-062445 |
| 2025-12-31 | 2026-02-17 | $218.0M | 34 | 0001104659-26-016376 |
| 2025-09-30 | 2025-11-14 | $186.6M | 39 | 0001104659-25-112578 |